Germany's Sartorius has struck a deal to combine its biotech division with Stedim Biosystems. Sartorius emerges as the majority owner of a combined company called Sartorius Stedim Biotechnology. France's Stedim claims bragging rights as the pioneer for disposable bag systems for biopharmaceutical applications. Stedim also has a product segment consisting of door systems for aseptic transfer technology and a freeze-thaw technology.
"This transaction significantly accelerates our strategy to offer customers fully integrated solutions for next-generation biopharmaceutical manufacturing," Joachim Kreuzburg, CEO and chairman of Sartorius' executive board. "Our two companies' product array, technology platforms, and regional strengths are highly complementary. Therefore, we are a perfect match."
- see this release on the merger